Massive Bio Launches Oracle Cerner App for Trial Matching
Large Bio, a frontrunner in AI-powered oncology scientific trial matching, at present introduced the launch of its new key function on the Affected person Join app. This integration will empower each sufferers and healthcare suppliers by simplifying the method of accessing and using digital well being data (EHRs) for superior most cancers care and scientific trial enrollment.
This launch is a big step in fulfilling Large Bio’s latest pledge to the Facilities for Medicare & Medicaid Companies (CMS) to advance nationwide healthcare interoperability. The brand new utility addresses a long-standing problem in oncology: the fragmentation of affected person medical information. For sufferers, accessing and compiling their full medical historical past is usually a cumbersome course of, whereas for hospitals, screening eligible sufferers for scientific trials throughout giant populations is a serious operational hurdle.
The mixing with Oracle Cerner platform offers Large Bio with important attain into the U.S. healthcare system. With Epic and Cerner mixed serving almost two-thirds of all healthcare suppliers and over three-quarters of hospital capability, this entry is crucial for healthcare supply and interoperability efforts. This in depth protection means the overwhelming majority of affected person care, scientific workflows, and healthcare information administration in the US flows by means of these two EHR platforms.
Large Bio’s Cerner utility offers a two-pronged resolution. Sufferers can now seamlessly join their My Cerner Chart to their Large Bio profile, permitting them to tug their complete medical data with just some clicks. This empowers sufferers to take a extra lively function of their healthcare journey and ensures their information is prepared for evaluation by Large Bio’s superior, ASCO-featured multi-agentic neurosymbolic AI by means of its AI prescreening hubs.
For healthcare suppliers, the appliance introduces a robust bulk information retrieval function. Hospitals and most cancers facilities utilizing Cerner can now securely and effectively course of the data of a number of consented sufferers without delay. This performance is designed to dramatically scale back the time and sources required for scientific trial pre-screening, enabling analysis groups to establish potential trial candidates on a a lot bigger scale.
“Our mission is to make sure that each most cancers affected person has entry to the absolute best remedy choices, and that begins with breaking down information silos,” mentioned Selin Kurnaz, Ph.D., Co-founder and CEO of Large Bio. “By integrating with a number one EHR supplier like Cerner, we’re empowering sufferers to regulate their information and offering hospitals with the instruments they should speed up life-saving analysis. This can be a crucial step ahead in making scientific trial enrollment extra environment friendly and equitable.”
“For a affected person, time is of the essence. The power to immediately pull their medical historical past and match it towards 1000’s of scientific trials is usually a game-changer,” mentioned Dr. Arturo Loaiza-Bonilla, Co-founder and Chief Medical AI Officer of Large Bio. “For our hospital companions, the flexibility to run bulk information evaluation means they’ll provide extra trial alternatives to their affected person populations, advancing most cancers analysis and bettering affected person outcomes concurrently.”
Join with Large Bio: To study extra and join with the Large Bio workforce, go to us at our upcoming occasions:
- Digital Well being Awards Pavilion at HLTH in Las Vegas
- ESMO AI and Digital Well being in Berlin
- Google AI Most cancers Symposium in New York
The Large Bio utility is now obtainable for sufferers and healthcare techniques utilizing Cerner.
The submit Massive Bio Launches Oracle Cerner App for Trial Matching first appeared on AI-Tech Park.